- Home
- PIII vs SNES Comparison
PIII vs SNES Comparison
Compare PIII & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PIII | SNES |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.1M | 14.5M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | PIII | SNES |
|---|---|---|
| Price | $4.21 | $2.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $16.25 | $10.00 |
| AVG Volume (30 Days) | 10.7K | ★ 45.6K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,444,952,000.00 | $2,301,000.00 |
| Revenue This Year | N/A | $41.52 |
| Revenue Next Year | $12.27 | $77.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 39.37 |
| 52 Week Low | $4.01 | $1.30 |
| 52 Week High | $14.50 | $6.24 |
Technical Indicators
Market Signals| Indicator | PIII | SNES |
|---|---|---|
| Relative Strength Index (RSI) | 21.04 | 37.50 |
| Support Level | $5.01 | $2.23 |
| Resistance Level | $5.20 | $2.94 |
| Average True Range (ATR) | 0.22 | 0.20 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 2.48 | 17.50 |
Price Performance
Historical ComparisonAbout PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.